J Wu1, H Lin, D Liu, J Liu, N Wang, X Mei, J Sun, G Yang, X Zhang. 1. Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing 400010, China.
Abstract
BACKGROUND: Thioredoxin-interacting protein (Txnip), an inhibitor of thioredoxin (Trx), increases in diabetic nephropathy and promotes oxidative stress. The angiotensin II (Ang II) receptor blocker telmisartan may protect renal function in diabetic models and patients via multiple effects including antioxidation. However, its mechanism has not been fully elucidated, and its relationship to Txnip remains unclear. AIM: This study aimed to investigate whether telmisartan ameliorates oxidative stress by regulating Txnip and Trx expression in Type 2 diabetic rat kidneys and explore the possible relationship between renoprotection by telmisartan and Txnip. METHODS: Twenty-one rats were equally divided into control (C), streptozotocin-induced diabetic (D), and telmisartan- treated diabetic (T) groups. Txnip and Trx expression in rat kidneys was analyzed by immunohistochemistry, RTPCR, and western blot. Peroxisome proliferator-activated receptor- γ (PPARγ), NADPH oxidase activity, and parameters of renal function and oxidative stress were also measured. RESULTS: Trx and PPARγ were significantly decreased, and Txnip expression and NADPH oxidase activity markedly increased, in the D and T groups compared to the C group. After telmisartan treatment, Trx and PPARγ were upregulated, while Txnip expression and NADPH oxidase activity were downregulated. Parameters of renal function and oxidative stress were improved by telmisartan. CONCLUSION: Telmisartan ameliorates oxidative stress and protects renal function in Type 2 diabetic rat kidneys. The downregulation of Txnip by telmisartan may be associated with PPARγ activation.
BACKGROUND:Thioredoxin-interacting protein (Txnip), an inhibitor of thioredoxin (Trx), increases in diabetic nephropathy and promotes oxidative stress. The angiotensin II (Ang II) receptor blocker telmisartan may protect renal function in diabetic models and patients via multiple effects including antioxidation. However, its mechanism has not been fully elucidated, and its relationship to Txnip remains unclear. AIM: This study aimed to investigate whether telmisartan ameliorates oxidative stress by regulating Txnip and Trx expression in Type 2 diabeticrat kidneys and explore the possible relationship between renoprotection by telmisartan and Txnip. METHODS: Twenty-one rats were equally divided into control (C), streptozotocin-induced diabetic (D), and telmisartan- treated diabetic (T) groups. Txnip and Trx expression in rat kidneys was analyzed by immunohistochemistry, RTPCR, and western blot. Peroxisome proliferator-activated receptor- γ (PPARγ), NADPH oxidase activity, and parameters of renal function and oxidative stress were also measured. RESULTS:Trx and PPARγ were significantly decreased, and Txnip expression and NADPH oxidase activity markedly increased, in the D and T groups compared to the C group. After telmisartan treatment, Trx and PPARγ were upregulated, while Txnip expression and NADPH oxidase activity were downregulated. Parameters of renal function and oxidative stress were improved by telmisartan. CONCLUSION:Telmisartan ameliorates oxidative stress and protects renal function in Type 2 diabeticrat kidneys. The downregulation of Txnip by telmisartan may be associated with PPARγ activation.
Authors: Weier Qi; Xinming Chen; Richard E Gilbert; Yuan Zhang; Mark Waltham; Maria Schache; Darren J Kelly; Carol A Pollock Journal: Am J Pathol Date: 2007-08-03 Impact factor: 4.307
Authors: Philip Wenzel; Eberhard Schulz; Matthias Oelze; Johanna Müller; Swenja Schuhmacher; Mohamed S S Alhamdani; Johannes Debrezion; Marcus Hortmann; Kurt Reifenberg; Ingrid Fleming; Thomas Münzel; Andreas Daiber Journal: Free Radic Biol Med Date: 2008-05-23 Impact factor: 7.376
Authors: Andrew Advani; Richard E Gilbert; Kerri Thai; Renae M Gow; Robyn G Langham; Alison J Cox; Kim A Connelly; Yuan Zhang; Andrew M Herzenberg; Per Knud Christensen; Carol A Pollock; Weier Qi; Sih Min Tan; Hans-Henrik Parving; Darren J Kelly Journal: J Am Soc Nephrol Date: 2009-02-11 Impact factor: 10.121
Authors: P Christian Schulze; Jun Yoshioka; Tomosaburo Takahashi; Zhiheng He; George L King; Richard T Lee Journal: J Biol Chem Date: 2004-05-05 Impact factor: 5.157
Authors: Weier Qi; Xinming Chen; John Holian; Christina Y R Tan; Darren J Kelly; Carol A Pollock Journal: Am J Pathol Date: 2009-10-01 Impact factor: 4.307
Authors: Anu Shah; Ling Xia; Elodie A Y Masson; Chloe Gui; Abdul Momen; Eric A Shikatani; Mansoor Husain; Susan Quaggin; Rohan John; I G Fantus Journal: J Am Soc Nephrol Date: 2015-04-08 Impact factor: 10.121
Authors: Radko Komers; Bei Xu; Yi Fu; Aaron McClelland; Phillip Kantharidis; Amit Mittal; Herbert T Cohen; David M Cohen Journal: PLoS One Date: 2014-05-14 Impact factor: 3.240